What is MNKD's health score?

MANNKIND CORP (MNKD) has a TradeApes health score of 37 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MNKD's estimated fair value?

Based on our 5-year discounted cash flow model, MANNKIND CORP's estimated fair value is $2.63 per share, representing a -25.2% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is MNKD undervalued or overvalued?

Our model currently rates MNKD as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MNKD... Refresh in a moment for the full analysis.

MANNKIND CORP (MNKD)

Healthcare Overvalued low weak

$3.52

Updated: 2026-06-05

TradeApes Score

Financial Strength

15 Stressed

Operating Trend

55 Mixed

Relative Value

25 Stressed

Capital Allocation

55 Mixed

Risk

50 Mixed

Est. Fair Value $2.63

DCF Upside -25.2%

Sector Rank #3335 of 6846

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

Create an account for unlimited access

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.